Merck & Co., Inc. Public Float
Merck & Co., Inc. (MRK) had Public Float of $198.05 billion as of 2025-06-30, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-24
- 2025-06-30: Entity Public Float $198.05B.
- 2024-06-28: Entity Public Float $313.80B.
- 2023-06-30: Entity Public Float $292.93B.
- 2022-06-30: Entity Public Float $230.82B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $198.05B 10-K · filed 2026-02-24 |
| 2024-06-28 | $313.80B 10-K · filed 2025-02-25 |
| 2023-06-30 | $292.93B 10-K/A · filed 2024-04-11 |
| 2022-06-30 | $230.82B 10-K · filed 2023-02-24 |
| 2021-06-30 | $196.87B 10-K · filed 2022-02-25 |
| 2020-06-30 | $195.46B 10-K · filed 2021-02-25 |
| 2019-06-30 | $215.11B 10-K · filed 2020-02-26 |
| 2018-06-30 | $161.99B 10-K · filed 2019-02-27 |
| 2017-06-30 | $174.70B 10-K · filed 2018-02-27 |
| 2016-06-30 | $159.26B 10-K · filed 2017-02-28 |
| 2015-06-30 | $160.71B 10-K · filed 2016-02-26 |
| 2014-06-30 | $167.69B 10-K · filed 2015-02-27 |
| 2013-06-30 | $135.89B 10-K · filed 2014-02-27 |
| 2012-06-30 | $126.84B 10-K · filed 2013-02-28 |
| 2011-06-30 | $108.76B 10-K · filed 2012-02-28 |
| 2010-06-30 | $107.72B 10-Q · filed 2011-11-08 |
| 2009-06-30 | $41.00B 10-Q · filed 2010-11-08 |
| 2008-06-30 | $31.98B 10-Q · filed 2009-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |